Latest Updates
|
October 2011 New Drug Updates and
Additions
|
Designation
|
Brand Name
|
Generic Name
|
|
4SC-201, BYK408740
|
|
Resminostat
|
HuLuc63, BMS-901608 |
|
Elotuzumab |
Antibody 806, ch806, ABT-806 |
|
|
ADXS-HPV, ADXS11-001, Lm-LLO-E7 |
Lovaxin C |
|
ADXS31-164, ADXS-HEr2 |
Lovaxin B |
|
| ANX-514, formerly SDP-014 |
|
|
AT001, r84 |
|
|
APN311, ch14.18 |
|
|
APN411 |
|
|
APN401 |
|
|
Adult stem cells |
MultiStem |
|
CVAC-301, formerly Panvac-VF |
|
Familmarev/inalimarev |
Bay 73-4506 |
|
Regorafenib |
SHY03757, SH-Y03757A, ZK-219477, ZK219477, ZK-epothilone, BAY86-5302 |
ZK-EPO |
Sagopilone |
BiovaxID |
|
|
CPX-351 |
|
Cytarabine:daunorubicin |
CNTO 95, CNTO95 |
|
Intetumumab |
COTI-2 |
|
|
AT-406, Debio 1143 |
|
|
APC8024, BA7072, DN24-02 |
Neuvenge |
Lapuleucel-T |
LY2181308, ISIS-23722, ISIS 23722 |
|
|
|
|
Defibrotide |
ICT-107 |
|
|
huN901-DM1, BB-10901TAP, BB-10901, IMGN901 |
|
Lorvotuzumab mertansine |
Y90 MAb LL2, 90Y-hLL2 |
LymphoCide Y-90 |
Epratuzumab |
| IMMU-106, hA20, hCD20 |
|
Veltuzumab |
INK1117 |
|
|
CP-675,206, CP-675, CP-675206 |
|
Tremelimumab (formerly ticilimumab) |
| AP23573, MK-8669 |
|
Ridaforolimus (formerly deforolimus) |
MK2206, MK-2206 |
|
|
L-BLP25, BLP-25 (formerly BP1-7-KLH), EMD531444 |
Stimuvax |
Emepepimut-S |
MIP-120T, Ultratrace MIBG |
Azedra, Ultratrace iobenguane I-131 |
Iobenguane I 131 |
MORAb-003 |
|
Farletuzumab |
3G4 |
Tarvacin |
Bavituximab |
PSMA ADC |
|
|
HKI-272 |
|
Neratinib |
TLN-4601, ECO-04601, ECO-4601, MW 462 |
|
|
INXN 2001/INX1001, Ad-RTS-IL-12, ZIN ATI-001 |
|
|
|
NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE: 1-949-830-0448 FAX: 1-949-830-0887
INFO@NEWMEDINC.COM
|